Anemia Studies in CKD: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat- Iron (ASCEND: Fe)
Clinical trial NCT03457701 · COMPLETED
Trial details
- NCT number
- NCT03457701
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-30
- Primary completion
- 2022-07-05
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.